Shaw Rietkerk Sells 25,000 Shares of AdaptHealth Corp. (NASDAQ:AHCO) Stock

AdaptHealth Corp. (NASDAQ:AHCO) COO Shaw Rietkerk sold 25,000 shares of AdaptHealth stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the transaction, the chief operating officer now owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

AdaptHealth Price Performance

AdaptHealth stock opened at $10.19 on Thursday. The firm’s 50-day moving average is $10.75 and its two-hundred day moving average is $10.44. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.15 and a quick ratio of 0.94. The stock has a market capitalization of $1.37 billion, a P/E ratio of -1.93, a P/E/G ratio of 1.73 and a beta of 1.10. AdaptHealth Corp. has a 12-month low of $6.37 and a 12-month high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The business had revenue of $805.98 million for the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a positive return on equity of 9.58% and a negative net margin of 21.20%. AdaptHealth’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.16 EPS. Equities analysts predict that AdaptHealth Corp. will post 0.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada restated an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, AdaptHealth presently has an average rating of “Hold” and a consensus price target of $10.70.

Institutional Investors Weigh In On AdaptHealth

Several hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC increased its position in AdaptHealth by 197.1% during the first quarter. GAMMA Investing LLC now owns 2,537 shares of the company’s stock worth $29,000 after purchasing an additional 1,683 shares during the last quarter. Covestor Ltd increased its holdings in shares of AdaptHealth by 279.6% during the 1st quarter. Covestor Ltd now owns 3,109 shares of the company’s stock worth $36,000 after buying an additional 2,290 shares during the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of AdaptHealth in the 2nd quarter worth $58,000. Blue Trust Inc. acquired a new position in AdaptHealth in the second quarter valued at $85,000. Finally, Innealta Capital LLC purchased a new stake in AdaptHealth during the second quarter valued at about $101,000. 82.67% of the stock is owned by institutional investors and hedge funds.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.